Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: AIDS. 2022 Aug 10;36(13):1801–1809. doi: 10.1097/QAD.0000000000003346

Table 4:

Adjusted Associations Between Gender (TW vs CM) and Biomarker Concentrations

Difference in Log Biomarker (95% CI) P-value
Adiponectin (ng/mL) 0.06 (−0.20, 0.33) 0.648
ENRAGE (pg/mL) 1.82 (1.58, 2.06) <0.001
LpPLA2 (ng/mL) 0.06 (−0.03, 0.15) 0.209
Oxidized LDL (mU/L) 0.26 (0.12, 0.39) <0.001
sCD14 (ng/mL) −0.09 (−0.19, −0.00) 0.048
sCD163 (ng/mL) −0.27 (−0.47, −0.08) 0.007
sTNFR I (pg/mL) 0.20 (0.07, 0.34) 0.003
sTNFR II (pg/mL) 0.17 (0.03, 0.30) 0.017
VCAM-1 (ng/mL) −0.05 (−0.17, 0.07) 0.425
VWF (mU/mL) −0.41 (−0.63, −0.19) <0.001
P-Selectin (ug/mL) 0.26 (0.08, 0.45) 0.006
Endothelin-1 (pg/mL) −0.35 (−0.64, −0.05) 0.021
IL-6 (pg/mL) 0.53 (0.12, 0.94) 0.012
IL-8 (pg/mL) 2.08 (1.49, 2.67) <0.001
PAI-1 (pg/mL) 0.67 (0.50, 0.83) <0.001

Adjusted for HIV serostatus, age, race/ethnicity, BMI, and smoking status; TW=transgender women, CM=cisgender males